Cargando…

TRPV1: A Potential Drug Target for Treating Various Diseases

Transient receptor potential vanilloid 1 (TRPV1) is an ion channel present on sensory neurons which is activated by heat, protons, capsaicin and a variety of endogenous lipids termed endovanilloids. As such, TRPV1 serves as a multimodal sensor of noxious stimuli which could trigger counteractive mea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brito, Rafael, Sheth, Sandeep, Mukherjea, Debashree, Rybak, Leonard P., Ramkumar, Vickram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092862/ https://www.ncbi.nlm.nih.gov/pubmed/24861977 http://dx.doi.org/10.3390/cells3020517

Ejemplares similares

Adenosine Receptors: Expression, Function and Regulation
por: Sheth, Sandeep, et al.
Publicado: (2014)

Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
por: Sheth, Sandeep, et al.
Publicado: (2017)

Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss
por: Dhukhwa, Asmita, et al.
Publicado: (2021)

Local Drug Delivery for Prevention of Hearing Loss
por: Rybak, Leonard P., et al.
Publicado: (2019)

Ototoxicity of Non-aminoglycoside Antibiotics
por: Rybak, Leonard P., et al.
Publicado: (2021)

Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway
por: Sheth, Sandeep, et al.
Publicado: (2012)

Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity
por: Ramkumar, Vickram, et al.
Publicado: (2021)

The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss
por: Ghosh, Sumana, et al.
Publicado: (2018)

Targeting Inflammatory Processes Mediated by TRPVI and TNF-α for Treating Noise-Induced Hearing Loss
por: Dhukhwa, Asmita, et al.
Publicado: (2019)

Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss
por: Sheth, Sandeep, et al.
Publicado: (2019)

Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol
por: Al Aameri, Raheem F. H., et al.
Publicado: (2017)

Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea
por: Bhatta, Puspanjali, et al.
Publicado: (2019)

Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity
por: Borse, Vikrant, et al.
Publicado: (2017)

Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity
por: Al Aameri, Raheem F. H., et al.
Publicado: (2023)

TRPV1 Channel: A Potential Drug Target for Treating Epilepsy
por: Nazıroğlu, Mustafa
Publicado: (2015)

Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation
por: Kaur, T, et al.
Publicado: (2011)

Bladder Cancer and Urothelial Impairment: The Role of TRPV1 as Potential Drug Target
por: Mistretta, Francesco, et al.
Publicado: (2014)

TRPV1: A Target for Rational Drug Design
por: Carnevale, Vincenzo, et al.
Publicado: (2016)

TRPV Subfamily (TRPV2, TRPV3, TRPV4, TRPV5, and TRPV6) Gene and Protein Expression in Patients with Ulcerative Colitis
por: Toledo Mauriño, Joel J., et al.
Publicado: (2020)

TRPV3 in Drug Development
por: Broad, Lisa M., et al.
Publicado: (2016)

TRPV2: A Cancer Biomarker and Potential Therapeutic Target
por: Siveen, Kodappully S., et al.
Publicado: (2020)

TRPV1: Role in Skin and Skin Diseases and Potential Target for Improving Wound Healing
por: Bagood, Michelle D., et al.
Publicado: (2021)

Paradoxic effects of propofol on visceral pain induced by various TRPV1 agonists
por: JI, WENJIN, et al.
Publicado: (2013)

Targeting TRPV1 for Body Weight Control using TRPV1(−/−) Mice and Electroacupuncture
por: Choowanthanapakorn, Monchanok, et al.
Publicado: (2015)

Role of TRPV1 and TRPA1 Ion Channels in Inflammatory Bowel Diseases: Potential Therapeutic Targets?
por: Csekő, Kata, et al.
Publicado: (2019)

Physiological and Pathological Role of TRPV1, TRPV2 and TRPV4 Channels in Heart
por: Gorbunov, Alexandr S., et al.
Publicado: (2019)

TRPV4 as a target for bladder overactivity
por: Angelico, Patrizia, et al.
Publicado: (2010)

TRPV6 as A Target for Cancer Therapy
por: Stewart, John M.
Publicado: (2020)

TRPV1 as an anti-ferroptotic target in osteoarthritis
por: Riegger, Jana
Publicado: (2022)

Expression of transient receptor potential vanilloid channels TRPV5 and TRPV6 in retinal pigment epithelium
por: Kennedy, Brian G., et al.
Publicado: (2010)

Cannabinoid-based drugs targeting CB(1) and TRPV1, the sympathetic nervous system, and arthritis
por: Lowin, Torsten, et al.
Publicado: (2015)

Inflammation up-regulates cochlear expression of TRPV1 to potentiate drug-induced hearing loss
por: Jiang, Meiyan, et al.
Publicado: (2019)

Investigation of Potential Drug Targets for Cholesterol Regulation to Treat Alzheimer’s Disease
por: Passero, Marina, et al.
Publicado: (2023)

TRPV1: A Target for Next Generation Analgesics
por: Premkumar, Louis S, et al.
Publicado: (2008)

TRPV3: Structure, Diseases and Modulators
por: Su, Wuyue, et al.
Publicado: (2023)

The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
por: Lowe, Henry, et al.
Publicado: (2021)

Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases
por: Ahmed, Rakin, et al.
Publicado: (2023)

Association of TRPV1 and TLR4 through the TIR domain potentiates TRPV1 activity by blocking activation-induced desensitization
por: Min, Hyunjung, et al.
Publicado: (2018)

TRPV1: A promising therapeutic target for skin aging and inflammatory skin diseases
por: Xiao, Tengfei, et al.
Publicado: (2023)

The potential role of TRPV1 in pulmonary hypertension: Angel or demon?
por: Zhang, Xin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_llqgluetbg4al3bv9p78io9tm5